When Dave Dombrowski said the Red Sox weren't going to have a ''big expenditure'' for the closer's role, he wasn't kidding.
The Sox reached an agreement with Jenrry Mejia Tuesday on a minor-league deal that would pay Mejia $625,000 if he reaches the major leagues.
Mejia, 29, last pitched in the big leagues in the summer of 2015, when he was suspended for a third PED violation.
Mejia served as the New York Mets closer in 2014, and was suspended for 80 games in April of 2015 after testing positive for Stanozolol, a steroid popular with body builders. Mejia maintained his innocence and said at the time: "I can honestly say I have no idea how a banned substance got in my system.''
He returned from that suspension in July, but after appearing in just seven games, tested positive again -- again, Stanozolol was found in his system along with traces of Boldenone, another anabolic steroid.
The third suspension, which came the following February, earned Mejia a permanent ban by baseball. Under the joint drug agreement between MLB and the Players Association, Mejia was allowed to apply for reinstatement after a two-year ban, and that conditional reinstatement was granted by commissioner Rob Manfred last July.
He appeared in two games in the minors last summer before the team released him in November.
In 113 appearances in his career -- 95 of which came in relief -- Mejia has a 3.68 ERA and a career WHIP of 1.484. He's averaged 8.0 strikeouts per nine innings in his career and has compiled 28 saves.